DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,348,632,971 | +0.6% | 21,558,375 | -2.6% | 0.46% | +3.6% |
| Q2 2023 | $5,314,802,016 | -50.9% | 22,145,009 | -48.4% | 0.45% | -9.9% |
| Q1 2023 | $10,814,680,678 | +67.4% | 42,908,590 | +76.3% | 0.50% | -22.9% |
| Q4 2022 | $6,461,036,718 | -3.0% | 24,342,690 | -5.6% | 0.64% | -7.6% |
| Q3 2022 | $6,660,374,000 | +3.0% | 25,786,419 | +1.1% | 0.70% | +7.9% |
| Q2 2022 | $6,467,351,000 | -12.9% | 25,510,224 | +0.8% | 0.64% | +8.6% |
| Q1 2022 | $7,423,970,000 | -23.5% | 25,309,277 | -14.2% | 0.59% | -17.3% |
| Q4 2021 | $9,703,398,000 | +8.2% | 29,492,716 | +0.2% | 0.72% | +0.8% |
| Q3 2021 | $8,964,650,000 | +16.8% | 29,446,358 | +2.9% | 0.71% | +18.3% |
| Q2 2021 | $7,676,306,000 | +19.6% | 28,604,508 | +0.3% | 0.60% | +9.7% |
| Q1 2021 | $6,418,877,000 | -7.2% | 28,518,206 | -8.4% | 0.55% | -10.9% |
| Q4 2020 | $6,917,740,000 | +7.1% | 31,141,354 | +3.8% | 0.62% | -5.8% |
| Q3 2020 | $6,460,995,000 | +38.6% | 30,005,084 | +13.8% | 0.65% | +27.5% |
| Q2 2020 | $4,660,891,000 | +37.9% | 26,358,032 | +7.9% | 0.51% | +9.4% |
| Q1 2020 | $3,380,268,000 | -15.4% | 24,422,141 | -6.2% | 0.47% | +6.1% |
| Q4 2019 | $3,994,052,000 | -0.8% | 26,023,274 | -6.6% | 0.44% | -8.7% |
| Q3 2019 | $4,024,335,000 | +1.0% | 27,863,575 | -0.1% | 0.48% | +3.9% |
| Q2 2019 | $3,984,282,000 | +9.1% | 27,877,712 | +0.7% | 0.46% | +6.2% |
| Q1 2019 | $3,653,196,000 | +60.8% | 27,671,543 | +25.6% | 0.44% | +40.8% |
| Q4 2018 | $2,272,336,000 | -3.8% | 22,035,846 | +1.4% | 0.31% | +16.9% |
| Q3 2018 | $2,362,241,000 | +13.9% | 21,739,751 | +3.5% | 0.27% | +11.3% |
| Q2 2018 | $2,073,369,000 | +11.2% | 21,011,026 | +10.3% | 0.24% | +8.1% |
| Q1 2018 | $1,864,982,000 | -0.3% | 19,047,910 | -5.5% | 0.22% | +0.9% |
| Q4 2017 | $1,869,990,000 | +4.6% | 20,146,422 | -3.4% | 0.22% | +1.4% |
| Q3 2017 | $1,788,592,000 | +8.0% | 20,850,939 | +6.3% | 0.22% | +4.9% |
| Q2 2017 | $1,656,100,000 | -0.4% | 19,624,350 | +0.9% | 0.21% | -2.4% |
| Q1 2017 | $1,662,803,000 | +10.2% | 19,441,167 | +0.3% | 0.21% | +4.5% |
| Q4 2016 | $1,509,142,000 | -29.5% | 19,387,738 | -29.0% | 0.20% | -29.1% |
| Q3 2016 | $2,139,187,000 | -41.1% | 27,289,042 | -24.2% | 0.28% | -42.5% |
| Q2 2016 | $3,634,752,000 | +10.0% | 35,987,650 | +3.3% | 0.50% | +8.5% |
| Q1 2016 | $3,303,251,000 | -7.8% | 34,822,379 | -9.7% | 0.46% | -5.2% |
| Q4 2015 | $3,581,567,000 | +11.1% | 38,561,238 | +1.9% | 0.48% | +5.0% |
| Q3 2015 | $3,224,276,000 | -8.7% | 37,839,183 | -8.3% | 0.46% | +1.5% |
| Q2 2015 | $3,529,892,000 | -1.8% | 41,241,871 | -2.6% | 0.45% | -1.3% |
| Q1 2015 | $3,594,656,000 | -0.9% | 42,339,883 | +0.1% | 0.46% | -3.0% |
| Q4 2014 | $3,626,327,000 | +12.3% | 42,309,266 | -0.4% | 0.47% | +8.0% |
| Q3 2014 | $3,228,375,000 | -16.2% | 42,489,798 | -13.2% | 0.44% | -15.3% |
| Q2 2014 | $3,852,210,000 | +4.5% | 48,929,383 | -0.5% | 0.52% | +0.8% |
| Q1 2014 | $3,687,634,000 | +2.7% | 49,168,453 | +5.7% | 0.51% | +0.8% |
| Q4 2013 | $3,592,052,000 | +22.0% | 46,529,184 | +9.6% | 0.51% | +12.6% |
| Q3 2013 | $2,943,868,000 | +27.6% | 42,467,786 | +16.5% | 0.45% | +19.3% |
| Q2 2013 | $2,307,537,000 | – | 36,453,989 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |